Berger et al., Novel Peroxisome Proliferator-activated Receptor (PPAR) gamma and PPARdelta Ligands Produce Distinct Biological Effects, J. Biol. Chem., 1999, 274:6718-6725. |
Brun et al., Peroxisome proliferator-activated receptor gamma and the control of adipogenesis, Curr. Opin. Lipidol., 1997, 8:212-218. |
Elbrecht et al., L-764406 is a partial agonist of human peroxisome proliferator-activated receptor gamma. The role of Cys313 in ligand binding, J. Biol. Chem., 1999, 274:7913-7922. |
Forman et al., 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma, Cell, 1995, 83:803-812. |
Greene et al., Isolation and cloning of human peroxisome proliferator activated receptor gamma cDNA, Adv. Exp. Med. Biol., 1997, 253-260. |
Greene et al., Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping, Gene Expr., 1995, 4:281-299. |
Hu et al., Transdifferentiation of mybolasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha, Proc. Natl. Acad. Sci. U. S. A., 1995, 92:9856-9860. |
Huang et al., Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase, Nature, 1999, 400:378-382. |
Jiang et al., PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines, Nature, 1998, 391:82-86. |
Kitamura et al., Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains, Biochem. Biophys. Res. Commun., 1999, 254:582-586. |
Kliewer et al., A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation, Cell, 1995, 83:813-819. |
Kubota et al., Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo, Cancer Res., 1998, 58:3344-3352. |
Lefebvre et al., Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice, Nat. Med., 1998, 4:1053-1057. |
Lehmann et al., An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma), J. Biol. Chem., 1995, 270:12953-12956. |
Mizukami et al., The antidiabetic agent thiazolidinedione stimulates the interaction between PPAR gamma and CBP, Biochem. Biophys. Res. Commun., 1997, 240:61-64. |
Mueller et al., Terminal differentiation of human breast cancer through PPAR gamma, Mol. Cell, 1998, 1:465-470. |
Murakami et al., A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats, Diabetes, 1998, 47:1841-1847. |
Palmer et al., cis-parinaric acid is a ligand for the human peroxisome proliferator activated receptor gamma: development of a novel spectrophotometric assay for the discovery of PPARgamma ligands, FEBS Lett., 1998, 431:476-480. |
Reginato et al., A potent antidiabetic thiazolidinedione with unique pereoxisome proliferator-activated receptor gamma-activating properties, J. Biol. Chem., 1998, 273:32679-32684. |
Ricote et al., Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein, Proc. Natl. Acad. Sci. U. S. A., 1998, 95:7614-7619. |
Ricote et al., The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation, Nature, 1998, 391:79-82. |
Saez et al., Activators of the nuclear receptor PPARgamma enhance colon polyp formation, Nat. Med., 1998, 4:1058-1061. |
Sarraf et al., Differentiation and reversal of malignant changes in colon cancer through PPARgamma [see comments], Nat. Med., 1998, 4:1046-1052. |
Sarraf et al., Loss-of-function mutations in PPAR gamma associated with human colon cancer, Mol. Cell., 1999, 3:799-804. |
Shao et al., Peroxisome proliferator activated receptor gamma, CCAAT/enhancer-binding protein alpha, and cell cycle status regulate the commitment to adipocyte differentiation, J. Biol. Chem., 1997, 272:21472-21478. |
Spiegelman, PPAR-gamma: adipogenic regulator and thiazolidinedione receptor, Diabetes, 1998, 47:507-514. |
Su et al., A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response, J. Clin. Invest., 1999, 104:383-389. |
Tontonoz et al., Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor, Cell, 1994, 79:1147-1156. |
Tontonoz et al., Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma, Curr. Opin. Genet. Dev., 1995, 5:571-576. |
Tontonoz et al., Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor, Proc. Natl. Acad. Sci. U. S. A., 1997, 94:237-241. |